Connect with:
Sunday / September 8. 2024
HomePosts Tagged "United States"

Groundwork BioAg expands Global commercialisation of mycorrhizal inoculants

Groundwork BioAg announced that its flagship mycorrhizal inoculant – Rootella – has been approved for commercialisation in China, Argentina, and South Africa, expanding farmers’ access to a climate-smart solution to optimise plant and soil health, adding approximately 677 million acres (274 million hectares) of harvested cropland to the company’s potential customer base.  

Over the last few years, Groundwork BioAg expanded commercialisation in the United States, Brazil, India, Canada, Ukraine, and other countries in Europe. With the addition of China, Argentina, and South Africa, the company and its local partners can offer farmers – including those in four of the top agricultural markets – access to the most highly concentrated mycorrhizal inoculant products available.

“Growers face mounting environmental and financial pressures to produce the food, fuel and fibre the world demands,” said Hanan Dor, Chief Commercial Officer at Groundwork BioAg. “As the leading mycorrhizal inoculant supplier, Groundwork BioAg is committed to partnering with local distributors to provide nature-based solutions that fit into modern farming practices and align with the world’s sustainability goals.”

Groundwork BioAg expands Global commercialisation of mycorrhizal

Reklemel active was discovered and developed by Corteva and is the result of more than a decade of research and investment

Plant-parasitic nematodes are microscopic organisms found in soil that feed on the roots of plants. Because they are notoriously difficult for farmers to identify and control, plant-parasitic nematodes represent a significant constraint to the delivery of global food security, causing damage estimated at or exceeding $80 billion per year.

To address this significant, global challenge, Corteva has launched Reklemel active, a new nematicide to help protect a wide variety of food and row crops from plant-parasitic nematode damage without disrupting the healthy balance of beneficial organisms in the soil. Reklemel active was discovered and developed by Corteva and is the result of more than a decade of research and investment.

“The future of global farming – and our ability to feed a growing population – rests on innovation. Reklemel demonstrates how Corteva deploys innovation to help farmers meet critical challenges to feed the world,” said Robert King, Executive Vice President, of Crop Protection Business, Corteva Agriscience.

Reklemel received a Reduced Risk designation from the U.S. Environmental Protection Agency (EPA) due to the product’s ability to selectively target plant-parasitic nematodes, its lower use rates than older nematicides, and its highly favourable environmental and toxicological profile as compared to alternatives. Reklemel is one of the first new active ingredients to be registered under EPA’s updated policy incorporating Endangered Species Act assessments into the pesticide registration process.

Reklemel also received the National Association of Manufacturers’ Sustainability and the Circular Economy Award in recognition that it, through lower use rates, enables the potential to avoid more than 500M Kg of CO2 – equivalent emissions over the next five years.2

Salibro nematicide with Reklemel active will be available in the United States, India and Mexico beginning in late 2023, and is currently available for sale in Canada and Australia. Additional registrations are planned globally, including in the European Union, subject to regulatory approvals.

Reklemel is the latest advance brought to market by Corteva to help farmers increase yields, meet climate and other challenges, and ultimately strengthen global food security. Corteva invests nearly $4 million every single day in research and development. In 2022, the company launched more than 180 new crop protection products globally and advanced nine new active ingredients in its R&D pipeline.

Reklemel active was discovered and developed by